Views
4 years ago

C4 - F Inserra, C Castellaro - 6/2016

  • Text
  • Aldosterona
  • Arterial
  • Arterial
  • Hta
  • Diureticos
  • Castellaro
  • Inserra
  • Cardiovascular
  • Niveles
  • Aldosterona
  • Tiazidas
  • Antihipertensivo
  • Estudio
  • Drogas
  • Arterial
  • Pacientes
  • Tratamiento
  • Efecto
Uso racional de diuréticos en el tratamiento de la hipertensión arterial

EM Ylarri //

EM Ylarri // Farmacología cardiovascular. De la molécula al paciente. Hipertensión arterial • Beckett NS, Peters R, Fletcher AE, et al. HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med.;358:1887-98, 2008. • PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet.;358:1033-1041, 2001. • Zheng Y, Cai GY, Chen XM, et al. Prevalence, awareness, treatment, and control of hypertension in the non-dialysis chronic kidney disease patients. Prevalence, Awareness, and Treatment Rates in Chronic Kidney Disease Patients with Hypertension in China (PATRIOTIC) Collaborative Group. Chin Med J (Engl). 126:2276-2280, 2013. • Brown NJ. Aldosterone and vascular inflammation. Hypertension 51:161-167, 2008. • Vongpatanasin W. Resistant hypertension: a review of diagnosis and management. JAMA. 311:2216- 2224, 2014. • Jamerson K, Weber MA, Bakris GL, et al.ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 359:2417-2428, 2008. • Dorsch MP, Gillespie BW, Erickson SR, et al. Chlorthalidone Reduces Cardiovascular Events Compared With Hydrochlorothiazide. A Retrospective Cohort Analysis. Hypertension. 57:689-694, 2011. • Roush GC, Holford TR, Guddati AK. Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses. Hypertension. 59:1110-1117, 2012. • Flack JM, Sica DA, Nesbitt Sh. Chlorthalidone Versus Hydrochlorothiazide as the Preferred Diuretic: Is There a Verdict Yet? Hypertension. 57:665-666, 2011. • NICE: National Institute for Health and Clinical Excellence (agosto 2011). • Mancia G, Fagard R, Narkiewicz K, et al. Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 31:1281-1357, 2013. • Guía para el diagnóstico, estudio, tratamiento y seguimiento de laHipertensión Arterial. www.saha.org.ar/Agosto2011. • Sica D, Carter B.Thiazide and loop diuretics. J ClinHypert, 13, 639-643, 2011. • Robinson D, Wellington K, Indapamide sustained release; a review of its use in the treatment of hypertension. Drugs 66:257-71, 2006. • Liamis G. A review of drug induced hyponatremia. Am J Kidney Dis 52:144-53, 2008. • Kasiske B et al, Effects of antihypertensive therapy on serum lipids. Ann Int Med122:133-41,1995. • Duarte J, Cooper De Hoff. Mechanisms for blood pressure lowering and metabolic effects of thiazide like diuretics. Exp Rev CardiovascTher 8:793-802, 2010. • Inserra F, Userpater M, Ferder M, Hoffman D, Ferder L. Thiazide diuretics do not protect against changes that accompany renal aging. J Nephrol 22:547-552, 2009. • Nakagawa T, Johnson RJ. Is there a dark side to thiazide therapy for hypertension? Nat Rev Nephrol 6:564-566, 2010. 56

Biblioteca

Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar

Editorial Sciens, Todos los Derechos Reservados 2015